Cognitive Impairment
📧 Sign up to get email alerts when something new happens for Cognitive Impairment.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Exercise in Adults With Mild Memory Problems [NA]
A completed clinical trial investigating exercise in adults with mild memory problems (mild cognitive impairment) with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Protecting Alzheimer Caregivers Using Technology Through Staying Sharp [Phase 1, Phase 2]
A Phase 1/2 clinical trial exploring technology-based interventions to support Alzheimer’s caregivers and address caregiver burden in indivi…
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study [Phase 4]
Phase 4 clinical trial investigating insulin resistance in individuals with mild cognitive impairment has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in Mild to Moderate Vascular Dementia [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Tian Ma Bian Chun Zhi Gan tablets for vascular dementia with cognitive impairment.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking) [Phase 2]
Phase 2 clinical trial update for NYX-458 in subjects with mild cognitive impairment or mild dementia due to Parkinson's disease or Lewy bod…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients [Phase 2, Phase 3]
A combined Phase 2/Phase 3 trial investigating silymarin to mitigate chemotherapy toxicity and improve cognition in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: The Effects of Intermittent Theta Burst Stimulation in MCI and Early AD [Phase 2]
Phase 2 trial evaluating intermittent theta burst stimulation for mild cognitive impairment and early Alzheimer’s disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19 [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating safety and dosage of a computerized cognitive training program for cognitive dysfunction following …
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Dose-response of Cannabis and Driving [Phase 2]
Phase 2 trial investigating dose-response of cannabis on driving impairment and cognitive effects; completed.
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Dapagliflozin Effect in Cognitive Impairment in Stroke Trial [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating dapagliflozin for cognitive impairment in stroke patients is in early or unknown status.
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: Candesartan's Effects on Alzheimer's Disease And Related Biomarkers [Phase 2]
Phase 2 clinical trial evaluating candesartan for mild cognitive impairment and its effects on Alzheimer's disease biomarkers has completed …
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors [Phase 1, Phase 2]
A clinical trial evaluating various doses of vitamin D for cancer-related cognitive impairment in patients with gastrointestinal tumors acro…
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: The Effects of Cannabidiol on the Driving Ability of Healthy Adults [Phase 2]
Phase 2 trial evaluating the effects of cannabidiol on driving ability in healthy adults, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Efficacy of Chinese Traditional Medicine "Smart Soup" in Cognition and Behavior Regulation in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial investigating a traditional Chinese medicine 'Smart Soup' for cognition and behavior regulation in Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment [NA]
Completed clinical trial studying adaptive neuroplasticity in individuals with mild cognitive impairment and Alzheimer's disease; results po…
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Clinical Trial of a Low Protein Diet in Patients With Cognitive Impairment [Phase 1, Phase 2]
Clinical trial update for a low protein diet in patients with cognitive impairment (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Improvisational Movement for People With Memory Loss and Their Caregivers [NA]
A completed clinical trial evaluating improvisational movement for people with memory loss and their caregivers has posted results.
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Effect of Elderberry Juice on Cognition and Inflammation in Patients With Mild Cognitive Impairment [Phase 1, Phase 2]
Clinical trial assessing elderberry juice effects on cognition and inflammation in mild cognitive impairment patients has completed phases 1…
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: The Cognition and Flow Study [NA]
Clinical trial update for the Cognition and Flow Study (NCT03656107) has been terminated with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-17Clinical Trial Update: Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating a computerized olfactory training program for cognitive decline in early Alzheimer's disease and mild cogn…
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Haloperidol for Delirium in Adult Critically Ill Patients [Phase 3]
A Phase 3 trial evaluating haloperidol for delirium in adult critically ill patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Nicotine Treatment of Cognitive Decline in Down Syndrome [Phase 1, Phase 2]
A completed phase 1/2 clinical trial evaluating nicotine treatment for cognitive decline in individuals with Down syndrome and mild cognitiv…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment [NA]
Clinical trial evaluating in-home technology support for caregivers of people with dementia and mild cognitive impairment has completed with…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment [EARLY_Phase 1]
Early-phase pharmacokinetics study of a Centella Asiatica product in mild cognitive impairment was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia [Phase 2]
Phase 2 safety and biomarker study of RL-007 in subjects with schizophrenia completed.